Telehealth sustains patient engagement in OUD treatment during COVID-19.  Langabeer JR 2nd, Yatsco A, Champagne-Langabeer T.  J Subst Abuse Treat. 2020 Nov 24:108215. doi: 10.1016/j.jsat.2020.108215. Epub ahead of print. PMID: 33248863;…

Changes in Outpatient Buprenorphine Dispensing During the COVID-19 Pandemic.  Cance JD, Doyle E.  JAMA. 2020;324(23):2442–2444. doi:10.1001/jama.2020.22154 https://jamanetwork.com/journals/jama/fullarticle/2774040

Mobile van delivery of extended-release buprenorphine and extended-release naltrexone for youth with OUD: An adaptation to the COVID-19 emergency.  Wenzel K, Fishman M.  J Subst Abuse Treat. 2021 Jan;120:108149. doi: 10.1016/j.jsat.2020…

Applying the lessons of COVID-19 response to Canada's worsening opioid epidemic.  Norton A, Kerr T.  EClinicalMedicine. 2020 Dec;29:100633. doi: 10.1016/j.eclinm.2020.100633. Epub 2020 Nov 20. PMID: 33235987; PMCID: PMC7677043. https://…

Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine.  Meteliuk A, Galvez de Leon SJ, Madden LM, Pykalo I, Fomenko T, Filippovych M, Farnum SO, Dvoryak S, Islam ZM, Altice FL.  J Subst Abus…

Integration of a contraception clinic into an opioid treatment setting to improve contraception knowledge, accessibility and uptake: a pilot study.  Day CA, White B, Reid SE, Fowler M, Black KI.  Aust N Z J Public Health. 2020 Oct;44(5)…